X-40580783-G-T
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The ENST00000436783.6(ATP6AP2):c.-111+1036G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00383 in 411,542 control chromosomes in the GnomAD database, including 18 homozygotes. There are 388 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0098 ( 13 hom., 289 hem., cov: 25)
Exomes 𝑓: 0.0016 ( 5 hom. 99 hem. )
Consequence
ATP6AP2
ENST00000436783.6 intron
ENST00000436783.6 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.53
Genes affected
ATP6AP2 (HGNC:18305): (ATPase H+ transporting accessory protein 2) This gene encodes a protein that is associated with adenosine triphosphatases (ATPases). Proton-translocating ATPases have fundamental roles in energy conservation, secondary active transport, acidification of intracellular compartments, and cellular pH homeostasis. There are three classes of ATPases- F, P, and V. The vacuolar (V-type) ATPases have a transmembrane proton-conducting sector and an extramembrane catalytic sector. The encoded protein has been found associated with the transmembrane sector of the V-type ATPases. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74).
BP6
Variant X-40580783-G-T is Benign according to our data. Variant chrX-40580783-G-T is described in ClinVar as [Likely_benign]. Clinvar id is 674230.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00981 (1107/112827) while in subpopulation AFR AF= 0.0339 (1053/31068). AF 95% confidence interval is 0.0322. There are 13 homozygotes in gnomad4. There are 289 alleles in male gnomad4 subpopulation. Median coverage is 25. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 13 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ATP6AP2 | ENST00000436783.6 | c.-111+1036G>T | intron_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.00982 AC: 1108AN: 112774Hom.: 13 Cov.: 25 AF XY: 0.00828 AC XY: 289AN XY: 34920
GnomAD3 genomes
AF:
AC:
1108
AN:
112774
Hom.:
Cov.:
25
AF XY:
AC XY:
289
AN XY:
34920
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00157 AC: 470AN: 298715Hom.: 5 AF XY: 0.00105 AC XY: 99AN XY: 94031
GnomAD4 exome
AF:
AC:
470
AN:
298715
Hom.:
AF XY:
AC XY:
99
AN XY:
94031
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00981 AC: 1107AN: 112827Hom.: 13 Cov.: 25 AF XY: 0.00826 AC XY: 289AN XY: 34983
GnomAD4 genome
AF:
AC:
1107
AN:
112827
Hom.:
Cov.:
25
AF XY:
AC XY:
289
AN XY:
34983
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 19, 2018 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at